Company Overview
Snapshot
Founded in June 2018 by Iddo Peleg and Gav Martell, Yonalink operates with 11–50 employees. The company has raised $7.6M across three funding rounds from three investors. In November 2022, Yonalink secured $6M in funding to scale global growth and expand its platform designed to stream clinical trial data.
Business overview
Yonalink provides data management solutions for clinical trials, focusing on streamlining the transfer of patient data. Its core technology is a SaaS platform designed to securely automate the streaming and mapping of up-to-date patient data from electronic health records (EHR) to electronic data capture (EDC) systems. The company aims to enhance the speed, quality, and efficiency of clinical trial operations globally, simplifying data collection and validation to enable scalability within the Health Tech & Life Sciences sector.
Strategic signal
In May 2026, Yonalink was acquired by Veeva, a significant development that validates Yonalink's AI platform for automating clinical trial data transfer. This acquisition signals a strong market demand for secure and efficient data integration solutions in clinical research, positioning Yonalink's technology for broader adoption and integration within Veeva's ecosystem.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent development for Yonalink?
- In May 2026, Veeva acquired Yonalink. This acquisition highlights the value of Yonalink's AI platform, which automates the secure transfer of data from medical records to clinical research systems while maintaining data security and privacy.
- When did Yonalink last raise funding and for what purpose?
- In November 2022, Yonalink raised $6M in funding. This capital was intended to scale global growth and fuel the expansion of its platform, which is designed to stream clinical trial data.
- Which organization selected Yonalink's platform in 2023?
- In March 2023, Hadassah selected Yonalink's EHR-to-EDC clinical trial platform. This integration aims to unify clinical care and research data, enhancing data management within their operations.
- Which investors participated in Yonalink's funding round in November 2022?
- In November 2022, Debiopharm Innovation Fund led a funding round for Yonalink, with participation from eHealth Ventures.
- Did Yonalink receive any grants?
- In May 2020, Yonalink received a grant of $500,000 from the Israel Innovation Authority.